Leerink Partners Sets Vera Therapeutics Price Target at $34 per Share
Leerink Partners announced a $34-per-share price target for Vera Therapeutics.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.